Skip to main content
. 2021 May 28;139(3):279–284. doi: 10.1590/1516-3180.2020.0457.R1.04022021

Table 3. Demographics, clinical characteristics and vitamin D status of the participants in the deep vein thrombosis (DVT) subgroups based on 25-hydroxyvitamin D (25(OH)D) status.

Characteristic Sufficient (n = 38) Insufficient (n = 50) Deficient (n = 192) P-value
Age (years) 59 (22-84) 63 (38-90) 61 (20-91) 0.500
Female gender, n (%) 20 (52.6%) 18 (36.0%) 104 (54.2%) 0.071
Height (cm) 167 (145-187) 165 (145-180) 168 (138-191) 0.227
Weight (kg) 77 (48-116) 75 (44-114) 76 (40-122) 0.916
BMI (kg/m2) 28.2 (18.2-37.1) 27.6 (19.3-38.8) 27.0 (19.5-44.1) 0.281
Obesity, n (%) 11 (28.9%) 17 (34.0%) 39 (20.3%) 0.096
Diabetes mellitus, n (%) 3 (7.9%) 8 (16.0%) 29 (15.1%) 0.474
Hypertension, n (%) 4 (10.5%) 5 (10.0%) 32 (16.7%) 0.367
Hyperlipidemia, n (%) 1 (2.6%) 8 (16.0%) 15 (7.8%) 0.500
Smoking, n (%) 12 (31.6%) 8 (16.0%) 52 (27.1%) 0.188
25(OH)D level, n (%) 9 (23.7%) 14 (28.0%) 117 (60.9%) < 0.001

BMI = body mass index; 25(OH)D = 25-hydroxyvitamin D.

Data are expressed as median (minimum-maximum) for continuous variables or number (%) for categorical variables.